These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 18385986

  • 41. Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.
    Stoker AK, Olivier B, Markou A.
    Behav Genet; 2012 May; 42(3):423-36. PubMed ID: 22009521
    [Abstract] [Full Text] [Related]

  • 42. Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice.
    Hilario MR, Turner JR, Blendy JA.
    Neuropsychopharmacology; 2012 Nov; 37(12):2661-70. PubMed ID: 22828747
    [Abstract] [Full Text] [Related]

  • 43. Nicotine withdrawal syndrome: behavioural distress and selective up-regulation of the cyclic AMP pathway in the amygdala.
    Tzavara ET, Monory K, Hanoune J, Nomikos GG.
    Eur J Neurosci; 2002 Jul; 16(1):149-53. PubMed ID: 12153540
    [Abstract] [Full Text] [Related]

  • 44. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats.
    Marcinkiewcz CA, Prado MM, Isaac SK, Marshall A, Rylkova D, Bruijnzeel AW.
    Neuropsychopharmacology; 2009 Jun; 34(7):1743-52. PubMed ID: 19145226
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Hildebrand BE, Nomikos GG, Hertel P, Schilström B, Svensson TH.
    Brain Res; 1998 Jan 01; 779(1-2):214-25. PubMed ID: 9473676
    [Abstract] [Full Text] [Related]

  • 47. Caffeine, nicotine and mecamylamine share stimulus properties in the preexposure conditioned taste aversion procedure.
    Kunin D, Bloch RT, Smith BR, Amit Z.
    Psychopharmacology (Berl); 2001 Dec 01; 159(1):70-6. PubMed ID: 11797072
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.
    Castañé A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O.
    Neuropharmacology; 2002 Oct 01; 43(5):857-67. PubMed ID: 12384171
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Nicotine vapor inhalation escalates nicotine self-administration.
    Gilpin NW, Whitaker AM, Baynes B, Abdel AY, Weil MT, George O.
    Addict Biol; 2014 Jul 01; 19(4):587-92. PubMed ID: 23240929
    [Abstract] [Full Text] [Related]

  • 52. Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal.
    Göktalay G, Cavun S, Levendusky MC, Hamilton JR, Millington WR.
    Eur J Pharmacol; 2006 Jan 13; 530(1-2):95-102. PubMed ID: 16364288
    [Abstract] [Full Text] [Related]

  • 53. Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats.
    Natividad LA, Tejeda HA, Torres OV, O'Dell LE.
    Synapse; 2010 Feb 13; 64(2):136-45. PubMed ID: 19771590
    [Abstract] [Full Text] [Related]

  • 54. Adolescent rats are resistant to adaptations in excitatory and inhibitory mechanisms that modulate mesolimbic dopamine during nicotine withdrawal.
    Natividad LA, Buczynski MW, Parsons LH, Torres OV, O'Dell LE.
    J Neurochem; 2012 Nov 13; 123(4):578-88. PubMed ID: 22905672
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Cholinergic transmission during nicotine withdrawal is influenced by age and pre-exposure to nicotine: implications for teenage smoking.
    Carcoba LM, Orfila JE, Natividad LA, Torres OV, Pipkin JA, Ferree PL, Castañeda E, Moss DE, O'Dell LE.
    Dev Neurosci; 2014 Nov 13; 36(3-4):347-55. PubMed ID: 24854235
    [Abstract] [Full Text] [Related]

  • 57. GABAB receptors blockage modulates somatic and aversive manifestations induced by nicotine withdrawal.
    Varani AP, Pedrón VT, Aon AJ, Canero EM, Balerio GN.
    Biomed Pharmacother; 2021 Aug 13; 140():111786. PubMed ID: 34144406
    [Abstract] [Full Text] [Related]

  • 58. Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.
    Biala G, Staniak N, Budzynska B.
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr 13; 381(4):361-70. PubMed ID: 20217050
    [Abstract] [Full Text] [Related]

  • 59. Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.
    Stoker AK, Semenova S, Markou A.
    Neuropharmacology; 2008 Jun 13; 54(8):1223-32. PubMed ID: 18452957
    [Abstract] [Full Text] [Related]

  • 60. Differential expression of nicotine withdrawal as a function of developmental age in the rat.
    Keeley RJ, Mayer TE, Hsu LM, Lu H, Yang Y, Stein EA.
    Pharmacol Biochem Behav; 2019 Dec 13; 187():172802. PubMed ID: 31669000
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.